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Technological advances over recent decades now allow for in vivo observation of human brain
tissue through the use of neuroimaging methods. While this field originated with techniques
capable of capturing macrostructural details of brain anatomy, modern methods such as
diffusion tensor imaging (DTI) that are now regularly implemented in research protocols
have the ability to characterize brain microstructure. DTI has been used to reveal subtle micro-anatomical abnormalities in the prodromal phase ofº various diseases and also to delineate
“normal” age-related changes in brain tissue across the lifespan. Nevertheless, imaging artifact
in DTI remains a significant limitation for identifying true neural signatures of disease and
brain-behavior relationships. Cerebrospinal fluid (CSF) contamination of brain voxels is a main
source of error on DTI scans that causes partial volume effects and reduces the accuracy of
tissue characterization. Several methods have been proposed to correct for CSF artifact though
many of these methods introduce new limitations that may preclude certain applications. The
purpose of this review is to discuss the complexity of signal acquisition as it relates to CSF
artifact on DTI scans and review methods of CSF suppression in DTI. We will then discuss
a technique that has been recently shown to effectively suppress the CSF signal in DTI data,
resulting in fewer errors and improved measurement of brain tissue. This approach and related
techniques have the potential to significantly improve our understanding of “normal” brain
aging and neuropsychiatric and neurodegenerative diseases. Considerations for next-level
applications are discussed.
Key words: MRI; DTI; Partial volume effects; CSF suppression

INTRODUCTION
Advances in radiology over the past several decades have drastically increased the ability to examine
the living human brain in detail. The introduction
of computed tomography (CT) allowed for low-resolution three-dimensional reconstruction of brain

tissue and represented a landmark improvement in
medical care potential (37). The subsequent technique
of magnetic resonance imaging (MRI) has continued
to expand the potential of in vivo imaging technology
(45). Clinical MRI is now commonly performed using
MR systems operating at a1.5 Tesla (T) field strength,
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with 3T and higher fields becoming ever increasingly
common for both clinical and research applications
(58,86). High-field imaging provides an invaluable
tool for identification of various brain disorders with
the goal of informing therapeutic methods and eventual cures.
In conjunction with the notable potential of these
technologies to answer important questions about
brain health, key technical components merit attention to optimize analytical procedures in both clinical
and research settings. Examples of these components
include the MR pulse sequence parameters, traditional methods of maximizing spatial accuracy of
resulting images, and modern advances that exploit
patterns of molecular movements within tissues to
illustrate cellular integrity in greater detail, with particular regard to diffusion tensor imaging (DTI). This
review will discuss foundational elements of MRI
technology as it relates to diffusion MRI, explore
potential sources of error when using traditional
methods (e.g., cerebrospinal fluid (CSF) contamination), and propose an acquisition and post-processing
approach to better manage artifacts associated with
this phenomenon.
SOURCES OF VARIANCE IN THE MR SIGNAL
Structural imaging techniques are based on the
nuclear spin of a hydrogen nucleus composed of a
single charged proton. Viewing this phenomenon
classically, the combination of nuclear spin and electrical charge can be considered to generate a “magnetic moment” that aligns with the external magnetic
field (B0). Because of these nuclear moments, a large
ensemble of nuclear spins (e.g., water) generates a
net magnetization. In a constant magnetic field, the
net magnetization is a vector that has points along
the z axis that runs parallel to B0 (i.e., the longitudinal direction) and a transverse component that
lies in the x-y plane that is perpendicular to B0. In
MRI, this net magnetization is detected by tipping
the net magnetization vector from the longitudinal
direction into the x-y plane (i.e., transverse plane),
where the MRI scanner can detect it independent
of the main magnetic field (B0). The magnetization
is tipped by applying a radiofrequency (RF) pulse
that has a time-varying field that oscillates in the x-y

plane. The RF pulse is applied at the characteristic
frequency (Larmor frequency) of the hydrogen nucleus. The Larmor frequency changes in proportion
to changes in magnetic field strength. A 90° RF pulse
tips the magnetization entirely into the transverse
(x-y) plane. The longitudinal magnetization is zero
after the 90° pulse. Typical pulse sequences utilize
a 90° RF pulse to maximize signal detection. Once
the RF pulse is turned off, the longitudinal magnetization begins to grow back through a process called
longitudinal relaxation (T1 relaxation). At the same
time, the transverse magnetization vector rotates in
the transverse plane at the Larmor frequency, and
the transverse vector magnitude (length) decays to
zero by a faster process called transverse relaxation
(T2 relaxation) (14,29,86).
There are different physical mechanisms that influence T1 and T2 relaxation times (14). Pertinent to
this review, relaxation times for both T1 and T2 vary
by tissue composition according to the surrounding
chemical environment of water protons (91). Water
nuclei in fat and water have similar Larmor frequencies; therefore, fat is visible on MR images. However,
due to the different physical environments between
fat and water, fat has a short T1 and T2 (i.e., fast longitudinal and transverse relaxation). By contrast, brain
gray matter and white matter have an intermediate T1
and T2, while pure water and CSF have a long T1 and
T2 due to intrinsic biophysical factors (13,41,80,91).
Image Formation and Contrast
Image formation relies on the spatial encoding of
the signal generated by the net transverse magnetic
vector rotating in the transverse plane (91). The MRI
signal is detected by an RF receiver coil that is similar
to the RF coil used to tip the net magnetization (RF
transmit coil). The RF receiver coil simply “listens”
to the transverse magnetization vector after the RF
transmit coil is turned off. Each time the transverse
magnetization rotates 360° in the transverse plane,
a peak voltage is generated in the receiver coil and
then digitized. The MR signal then becomes an oscillating voltage that has a frequency equal to the
Larmor frequency but contains no information indicating the location of signal generation in the brain.
The signal is spatially encoded by applying external
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magnetic field gradients across the brain that alter the
strength of B0 in a predictable pattern that causes a
change in the resonance Larmor frequency according
to position. As a result, the transverse magnetization
rotates at different frequencies at different positions
across the brain. The variations in signal frequency are transmitted through the RF receiver coil and
distinguished as spatial frequencies using a Fourier
Transform (FT). A similar second spatial encoding is
completed in the perpendicular direction across the
brain. The signals are digitized and stored as raw data
points on a two-dimensional grid (“k-space”) and
then reconstructed by the FT to produce an image.
Each discrete data point in the reconstructed image is
called a pixel (i.e., a picture element). The brightness
of each pixel corresponds to the sum of the MRI signals in the corresponding small rectangular volume
of tissue called a voxel (i.e., the volume element). At
each point in the image, the brightness is proportional
to the signal intensity generated by the total transverse magnetization in that corresponding voxel of
the brain. Thus, the image intensity depends on the
number (density) of hydrogen nuclei and the T1 and
T2 in a specific area of brain tissue (29,91).
Differences in relaxation times between tissues
(e.g., gray and white matter, CSF) produce different
signal intensity contrasts in the image. The degree to
which an MRI scan is sensitive to differences in T1 or
T2 is controlled by the operator of the scanner. Most
images are created using a “spin-echo,” which is a basic
pulse sequence that consists of operator-modifiable
parameters such as echo time (TE) and repetition
time (TR). TE is the time between the initial RF pulse
and the peak of the signal, whereas TR is the time
between consecutive RF pulses. A pulse sequence
with short TR and TE is sensitive to differences in T1,
and the resulting image is called a T1-weighted image.
In such an image, tissues with a long T1 (e.g., CSF)
appear dark. A pulse sequence with long TR and TE
produces a T2-weighted image, in which tissues with
a long T2 (e.g., CSF) appear bright (14,54,91). Thus,
selecting the correct pulse sequence setting is critical
for determining the relative visibility of certain brain
structures and neuropathology.
Diffusion-weighted imaging (DWI) is an alternative approach to capture tissue contrast that depends
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on the random microscopic movements of water
molecules (i.e., diffusion) in brain tissue (26,46,84 92).
In DWI, strong magnetic field gradients are applied
during a T2-weighted spin-echo pulse sequence to
make the sequence sensitive to water diffusion. After
applying the RF pulse to tip the net magnetization into
the transverse plane, a diffusion-encoding gradient
is applied along one direction, such that the B0 field
is higher in one direction and lower in the opposite
direction. As water molecules begin to move around
randomly in the tissue, some molecules will move to
areas with higher resonant frequencies, and others
will move to areas with lower resonant frequencies.
The net result is a direct interference in the MR signal that causes signal loss. Signal loss is more severe
if diffusion is faster and the diffusion gradients are
stronger.
Adjusting the strength of the diffusion-encoding
gradient adjusts the strength of the diffusion weighting (i.e., b value). Higher b values indicate stronger
diffusion sensitivity, up to a b value given by bD = 1,
where D is the diffusion coefficient or “diffusivity” (D
~ 10-3 mm2/s in brain tissue). Thus, a b value of 1000
s/mm2 is typically used in DWI. A higher b value will
reduce the signal intensities and produce a darker
image at that tissue location (18,26). Because DWI
is also T2-weighted, “T2-shine through” effects can
occur from the bright signal intensities of free-water.
These T2 effects can be eliminated by calculating the
diffusion coefficient (D) from images with two different b values (typically from a T2-weighted image
with b~0 and a DWI) (70). Because the diffusion
coefficient depends on complex factors in tissue, it
is sometimes referred to as the apparent diffusion
coefficient (ADC). Thus, the observed D in tissues
represents the effective rate of diffusion in an image
voxel. To measure D, DWI sequences sometimes utilize at least two different b-values to plot the best-fit
D using the log of the signal intensity measured in a
specific tissue (26).
Diffusion encoding gradients can be applied along
three orthogonal axes to produce three different DWI
contrasts that provide information regarding the directionality of water motion. Water molecules that
diffuse in tissues composed of fibers (e.g., white matter) move rapidly along the fiber, but slowly across
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the fiber due to fiber walls that act as barriers (80). In
these tissues, water diffusion is anisotropic (i.e., varies
along different directions). Water molecules in pure
water do not encounter barriers and travel quickly
and equally in all directions (isotropic diffusion). For
tissue that is generally isotropic (e.g., gray matter and
CSF), water molecules follow a random pattern of
motion, and the signal loss is not dependent on the
direction of the diffusion-encoding gradient. In these
tissues, a single scalar D is sufficient to characterize
diffusion (26). By contrast, the signal loss in anisotropic tissue (e.g., white matter) strongly depends on the
direction of white matter fibers and the diffusion-encoding gradients, which complicate interpretation of
DWI contrast. Thus, the directionally-averaged D (or
mean diffusivity (MD) image) is often calculated in
clinical practice, which is the average of the computed
D images obtained from the orthogonal encoding
directions. Sometimes the average DWI or isotropic
DWI (DWIiso) is also shown, which is the geometric
mean of the corresponding DWIs. In both MD and
DWIiso, the effects of white matter fiber direction have
been removed. For a more complete description of the
directional motion of water molecules in anisotropic
tissues, a diffusion tensor is required (9,10,19).
DIFFUSION TENSOR IMAGING
Derivation of the diffusion tensor from the DWIs
allows for the quantification of water diffusion in
living brain tissue, thus providing information about
the underlying tissue microstructure. The diffusion
tensor characterizes the three-dimensional spread
of diffusing water molecules from a point source
using three-dimensional ellipsoids. Various biological
factors influence the shape of the diffusion ellipsoid,
including the microstructural composition of human
brain tissue. DTI scan protocols require the application of at least six non-collinear diffusion-encoding
gradients and a reference image (typically a b~0 image) to capture the full extent of directional water
mobility in anisotropic tissue voxels (an anisotropic
tissue voxel is a voxel that is, for example, 2x2x5mm
in dimensions) (19,63). Modern research scan protocols tend to utilize many more directions (up to 64)
to increase the sensitivity of the signal and improve
measurement accuracy (35).

The majority of work utilizing DTI has focused
on white matter integrity, as changes in white matter
microstructure can be readily delineated using DTI
metrics. White matter primarily consists of myelinated and unmyelinated axon fibers that restrict water
movement in directions perpendicular to the fibers,
thus increasing anisotropy (56). Damage to axons
and/or the myelin sheath reduces anisotropy and
increases the rate of diffusion in directions perpendicular to the fibers, which is a common result of aging
and disease (4,56,82). DTI can also be used to evaluate
changes in gray matter microstructure, though the
biological interpretation of gray matter diffusion is
less clear than in white matter due to the high level
of isotropic diffusion that is evident in normal-appearing gray matter (4,28). Increases in gray matter
diffusion have been reported in previous studies of
aging (59,68,75,76), yet the mechanisms underlying
these changes have not been fully delineated.
Fractional anisotropy (FA) and MD are traditional
DTI scalar metrics that measure diffusion processes
by quantifying the degree of directionality of water
diffusion and the directionally-averaged rate of water movement within an image voxel, respectively
(15). Damage to cellular microstructure (e.g., axon
degeneration, myelin loss, etc.) alters the movements
of water molecules and typically results in increased
MD and decreased FA (3). Axial diffusivity (AD) and
radial diffusivity (RD) are additional DTI metrics
that measure water diffusion that occurs parallel and
perpendicular to axon fibers (60). Increased RD and
decreased AD are believed to reflect reduced integrity as a result of demyelination, axon damage, fiber
rarefaction, and/or gliosis (11).
TECHNICAL LIMITATIONS OF DTI
Numerous factors influence accuracy and precision of DTI data, including imperfections in scanner
hardware (e.g., RF coil, magnetic field gradients),
selection of operator controlled parameters (e.g.,
pulse sequence, number of acquisitions, number of
diffusion-encoding gradients), and patient variables
(e.g., motion) (55). As a result, quality control (QC)
of imaging data is critical for obtaining accurate
DTI measurements. Various QC procedures can be
implemented to minimize errors from multiple sources,
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and these procedures are often selected according
to the research question of interest. Despite these
efforts, certain image artifacts remain after correction, and the presence of these artifacts significantly limits research investigations utilizing diffusion
indices. Below, we review partial volume effects as
a key limitation to DTI applications, specifically in
the use of DTI to understand normal and abnormal
brain conditions.
Partial Volume Effects
Because the voxel signal is a sum of all tissue signals within the voxel (i.e., all transverse magnetization
vectors), finite image resolution inevitably causes
a mixture of signals at the interface of two tissues.
Qualitatively, this partial volume effect (PVE) can
cause loss of edge contrast between tissues occupying
the same voxel and can even obscure small lesions
near the interface between tissues (72). Quantitatively,
PVEs can cause errors in volumetric measurements
using structural MRI or region-of-interest (ROI) measurements using DTI. The PVE is more severe when
the signal difference between the two tissues is greater,
and when the tissue interface makes a shallow angle
with respect to the edge of the voxel. Such effects are
particularly strong when using a slice thickness that is
larger than the in-plane voxel dimensions (87) (e.g.,
non-isotropic voxel dimensions).
A main source of PVEs is CSF contamination of
gray matter on the surface of the cortical ribbon (42).
The CSF-gray matter PVE is particularly strong due to
the high contrast between CSF and gray matter on T1
and T2 -weighted images, and because of the undulations of the cortical ribbon that lead to unpredictably
shallow interface angles. Further, CSF-gray matter
PVEs manifest as errors in gray matter volumetric
measurements and ROIs that are proportional to the
ratio of surface area to volume of a measured tissue,
which is higher for gray matter. These artifacts are of
greater concern in studies of abnormal brain integrity
in normal aging and age-related disorders, as tissue
atrophy increases the magnitude of the PVE (12,88).
Thus, DTI examinations of clinical populations may
yield variable conclusions across studies as a result
of latent CSF PVEs. Further, voxels containing more
than one type of tissue will exhibit heterogeneous dif-
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fusion properties and produce biased measurements.
Signal contamination causes an overestimation of
MD and underestimation of FA (78) and represents
a major limitation for studies investigating brain
microstructure. Specifically, CSF PVEs have been
shown to reduce the biological approximation of DTI
parameters by as much as 15-60% in previous studies
(6,7,44).
Voxel and pixel size are important operator-controlled parameters that influence PVEs. Larger voxels
are more likely to include multiple brain structures
and therefore have a greater propensity for CSF contamination (2). This effect is often observed in gray
matter, where larger voxels are sometimes used to
enhance signal intensity of subcortical nuclei, though
the effect may also be observed in deep white matter
regions. Reducing the size of the image voxels will
reduce PVEs, yet this comes at a cost to the signalto-noise ratio (SNR) (78,95). Since these factors have
the potential to alter imaging analytical approaches,
an investigation into methods that can mitigate CSF
PVEs is warranted.
STRATEGIES TO REDUCE CSF CONTAMINATION
Initial attempts to control CSF PVEs relied on
fluid attenuated inversion recovery (FLAIR) (27).
The FLAIR sequence consists of an inversion pulse
at the beginning of the pulse sequence that tips the
net longitudinal magnetization 180° into the z plane.
The longitudinal magnetization then undergoes T1
relaxation to become positive. After the inversion
time (TI), signal is generated using a 90° RF pulse
(described earlier in this review). The TI interval
is chosen so that the CSF longitudinal magnetization recovers exactly at the time of the 90° RF pulse,
which ensures that the signal is not generated from
CSF. Because CSF has a longer T1 than gray or white
matter, the longitudinal magnetization of brain tissues
recovers to a positive value prior to the 90° pulse,
thus generating the signal. FLAIR also utilizes a long
TE to produce T2-hyperintense signals in fluid-filled
lesions near the ventricles (21,27). However, recovery of longitudinal magnetization in brain tissue is
incomplete and therefore reduces SNR.
The FLAIR approach can also be used to suppress
CSF signals in DTI by preparing the magnetization
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with a 180° RF pulse prior to the conventional DTI
pulse sequence (44,64). While several studies have
reported that FLAIR increases the accuracy of DTI
and DTI-based tractography measurements (17,64),
it also reduces SNR, reduces the number of slices,
increases scan time, and has limited utility at higher
magnetic field strengths (e.g., > 3T) (8,53). Further,
this technique is seldom utilized clinically, as FLAIRprepared DTI sequences require cardiac gating to
avoid motion artifact from cardiac pulsations (53).
Sub-Voxel Modeling as a Solution to CSF PVEs
Other previous efforts to resolve the problem of
CSF PVEs have relied on fitting a tissue tensor and a
CSF tensor (or CSF diffusion coefficient) to the DWI
data to account for mixed diffusion signals within
a voxel (53,65,66,69). The most common approach
is referred to as the “free water elimination” (FWE)
method of Pasternak et al. (65). This approach assumes that there are two subregions within a voxel
that demonstrate characteristic tensor signals for
brain tissue and free-water. By calculating separate
tensors for CSF versus brain tissue, the CSF contamination can be controlled. This FWE method uses a
single b value for diffusion weighting, and thus can
be used to analyze existing data acquired with typical
research DTI scan protocols. A variant of the FWE
method was also developed to give better estimates
of the free water component by acquiring and fitting
multiple “shells” of DWI data, with each shell providing tensor information and having a different b value
(66). This method also uses a different neighboring
voxel regularization scheme. While effective (53), this
multi-shell approach increases scan time significantly
(66).
FWE imposes constraints to a regularization bitensor model fitting to yield continuity between tissue
tensors of adjacent voxels. It has been stated that these
FWE methods enable estimation of the free water
fraction and the distinction between water from CSF
versus water from vasogenic edema (66). Because the
latter source of water signal is a result of physiologic
changes (e.g., aging, stroke, etc.) rather than partial
volume artifact, this method was thought to be suited
to removing CSF signal in brain scans of older individuals who may have pathologic sources of tissue

water. Technically, the FWE approaches are limited by
smoothing constraints that reduce sensitivity to subtle
microstructural abnormalities (47) and therefore may
not be ideal for certain research questions examining
brain changes in the early stages of disease.
A significant aspect of the sub-voxel modeling approaches described above is the modeling of free water and tissue signal components, and the assumption
that each component signals a non-monoexponential
pattern of signal decay (57). The exponentiality of signal decay likely depends on the range of b values used
and the dependence of tissue and CSF signal on the
b value (22,33,52,57). One view postulates that true
diffusion decay of brain parenchymal tissue is in fact
non-monoexponential (34,51,52), independent of the
CSF signal. A potential limitation of these approaches
that is not commonly discussed is that CSF in sulci
and ventricles often exhibits bulk flow and pulsatile
motion (49) and therefore may have a more complex
signal decay behavior compared to stationary water in
a container. Gaussian diffusion, in which molecular
water displacements have a Gaussian distribution,
forms the basis for the ellipsoid model of diffusion.
Several techniques have been developed to measure
non-Gaussian diffusion, such as q-space imaging (5),
diffusion kurtosis imaging (34), and diffusion spectrum imaging (90). While each of these approaches
has provided new insights into image analysis and
our understanding of neurophysiology, the theory
of diffusion-weighted signal decay in brain tissue
has not gained categorical acceptance, possibly due
to variations in the intra- and extracellular volume
fractions used across methods (52).
Alternative Techniques to Suppress the CSF
Signal
As an alternative to modeling the CSF signal component in the voxel, the CSF signal can be suppressed
using the diffusion-encoding gradients (as opposed
to using FLAIR). In developing such a model-independent approach, our group recently examined
CSF suppression and multiexponential decay in the
gray matter of older individuals (75). We analyzed
DWIiso images (computed as the geometric means
of the DWIs) efficiently acquired at 4 b values based
on the following pulse sequence: 5 acquisitions at
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b~0, 3 perpendicular directions at b = 680 s/mm2,
24 intermediate directions at b = 996 s/mm2, and
4 tetrahedral directions at b = 1412 s/mm2 (75). To
assess the potential effect of CSF PVEs on the decay
curve and the exponential nature of the signal decay,
signal intensities were graphed as a function of b
values for several bilateral ROIs, including perisulcal
gray matter (e.g., superior temporal gray matter),
periventricular gray matter (e.g., caudate), and gray
matter distant from CSF (e.g., putamen). Semilog
plots of the DWIiso signal intensity (geometric means)
versus b value in perisylvian gray matter revealed
that the b~0 signal was above the straight-line fit of
the three b ≥ 680 s/mm2 points (Figure 1). Further,
the b ≥ 680 s/mm2 points were observed to follow
a straight line, indicating that CSF contamination
is a source of non-monoexponential decay in gray
matter that can be suppressed with the removal of
the b~0 data. Importantly, this result also indicates
that the remaining data points from b ≥ 680 to 1412
s/mm2 followed a monoexponential pattern of decay,
demonstrating that a tensor can be accurately fit to
this range of b values without including b~0 data.
CSF suppression and tissue exponential decay were
further tested by comparing MD that was calculated from the results of three separate tensor-fitting
schemes: 1) the standard scheme in which all four b
values were included; 2) the nobase scheme in which
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only b~0 data were eliminated; and 3) the high-b
scheme in which only the two highest b values were
included. The results for the different schemes are
compared in Figure 2. First, MD measured by the
standard method was compared to MD from the
nobase method in the right superior temporal gray
matter (Figure 2a). Each data point in the scatterplot
represents a different subject. The deviation from
the line of identity is due to the CSF effect. A similar
deviation occurred for the standard versus high-b
methods (Figure 2b). In contrast, the nobase and
high-b results fell on the line of identity (Figure 2c),
which indicates that the CSF effect was eliminated
and that the b values between 680-1412 s/mm2 sample the same exponential decay curve. The smallest
difference across the three different fitting schemes
was observed for the putamen (1%, d < .4), which
was expected given its distal location to CSF areas.
Moderate differences were observed in the caudate
between standard and nobase, and between standard
and high-b methods (11%, d < .75). Even larger differences were observed in sulcal gray matter areas
(15%, d > 1.0). Differences between nobase and
high-b were negligible for nearly all brain regions
(1-2%), and these minor differences were likely a
result of the additional random noise caused by the
narrower range of b values in the high-b analyses
(note that all CSF correction methods have increased

Figure 1. Diffusion-weighted signal decay curve for right superior temporal gray
matter (GM) in one subject from the study by Salminen et al. (25). The isotropic
DWI (DWIiso) image was computed from the geometric mean of the DWIs at
each of the four b values (b~0 and b= 680, 996, and 1412 s/mm2). The DWIiso
signal intensity was measured from the geometric mean images using a ROI in
superior temporal GM. The log of the DWIiso is graphed versus b value so that
the monoexponentiality of signal decay can be assessed by the fit of the data to a
straight line. The solid red line is fit to the three b ≥ 680 s/mm2 data points. The
graph shows that the b~0 data point is artifactually above the dashed red line
that is extrapolated from the fit to the other three data points. The DWIiso images
at b~0 showed bright CSF signal, while the three DWIiso images with b ≥ 680
had absent CSF signal (not shown). Thus, the deviation in the b~0 data point
indicates partial volume averaging with CSF in the adjacent sulci and Sylvian
fissure. The observation that the three data points with b ≥ 680 fall on a straight
line indicates monoexponential decay of gray matter after removing CSF effects.
The artifactual deviation in the b~0 data due to CSF effects is somewhat muted
by the large ROI, which contains some voxels that are not adjacent to CSF (for
voxels adjacent to CSF spaces, the effect is stronger). The log of the ventricular
CSF signal deviated from linearity at all data points (not shown), indicating a
more complex signal behavior in CSF. The signal intensity and its log are in arbitraty units [a.u.].
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SNR). For example, the left putamen demonstrated a
subtle negative percent change between nobase and
high-b (-1.8%). Further study is needed to determine
whether this very small difference is due to a subtle
effect of CSF-like signals (e.g., Virchow-Robin spaces).
Similar phenomena can occur in white matter. A
semilog graph of the isotropic DWI signal versus b
value in white matter anterior to the temporal horns of

the lateral ventricle (Figure 3) shows deviation of the
b~0 data point, while the b ≥ 680 s/mm2 data points
fall on a straight line. This effect is indicative of a CSF
PVE in this white matter region and monoexponential
decay in the underlying white matter parenchyma
over the range of b values from 680 – 1412 s/mm2.
This monoexponentiality is important because it
enables accurate tensor measurement over a subset

Figure 2. Scatterplots demonstrating the difference between mean diffusivity (MD) measurements in superior temporal gray matter of the
right hemisphere (rh.superiortemporal) using the three different schemes: standard (all four b values), nobase (no b~0 data), and highb
(no b~0 data and no b ≥ 680 s/mm2 data). The diagonal black dashed lines are lines of identity. Figures 2a and 2b show that the standard
MD is overestimated with respect to the other measures. The agreement between nobase and high-b in Figure 2c indicates that nobase
effectively corrects for CSF PVEs. In Figure 2c, the slope is 0.965 +/- 0.041, and the y-intercept is 0.0293 x 10-3 +/- 0.0505 x 10-3 (+/- 1.0
standard error in each case), indicating agreement in the nobase and hi-b measures. Note that MD values are in units of mm2/s. Each
data point represents a ROI measurement for one participant in the study. Linear regression lines are shown (solid red), with regression
equations and R2 statistics given as text.
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of b values that exclude the b~0 data. It also enables
tensor fitting using a reduced number of encoding
directions at each b value, thus shortening the scan
time.
Recently, Baron and Beaulieu (8) independently
reported a similar approach to improve the accuracy
of DTI tractography using a non-zero b-minimum
(bmin = 425 s/mm2) and a relatively short TR (TR =
3.0 s). This study compared the effects of both parameters on fiber tracking. Specifically, they determined
the effects on pathway volume and diffusion scalar
metrics in pathways vulnerable to CSF PVEs (such
as the fornix) and also tracts that are less sensitive
to CSF (such as the superior longitudinal fasciculus, SLF). The combination of a short TR and bmin =
425 s/mm2 resulted in more than a 50% increase in
pathway volume for the crura and body of the fornix,
and a 14% increase in SLF volume. As a result, 30%
higher FA and 36% lower MD were observed in the
crura. These results are consistent with the trends
that would be expected if CSF contamination of tissue voxels were reduced. Percentage increases were
not reported using a non-zero b-minimum alone
without a short TR. DTI accuracy was also improved
for the body of the fornix and the SLF, though these
improvements were less robust. Interestingly, using a non-zero b-minimum without adjusting TR
produced nearly equivalent volumetric increases as
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the combined model in both tracts. Furthermore,
reducing TR alone did not significantly impact SLF
measurements, suggesting a greater effect of b~0 data
on CSF PVEs in white matter.
The significance of the above two methods that
omit the acquisition or analysis of b~0 is very high.
CSF contamination significantly reduces the accuracy
of DTI measurements and DTI-based tractography.
Artificially low FA values in voxels adjacent to CSF
can bias DTI measurements or cause tractography
to fail in these regions due to FA falling below the
tracking threshold (8). DTI measurements and
tractography of white matter fiber bundles, such as
the fornix, cingulum, uncinate fasciculus, and corpus callosum, may be particularly sensitive to CSF
PVEs given their anatomical proximity to CSF spaces.
Abnormalities in each of these structures have been
identified in normal aging and in various neurological conditions (e.g., dementia, multiple sclerosis,
schizophrenia, etc.) (31,43,96), and accurate DTI
measurements are critical for understanding the implications of these structural alterations. The fornix
is of particular interest in studies of neurodegenerative and neuropsychiatric disease, as it is a major
white matter projection from the hippocampus that
directly passes through the ventricles. As such, it is
highly susceptible to CSF contamination and requires
a corrective technique to remove CSF signal. Few

Figure 3. Semilog graph of the isotropic DWI signal (DWIiso) versus b value in
white matter. Measurement, analysis, and graphical display as described in Figure
1, except that the ROI in Figure 3 is in white matter posterior to the left temporal
pole. Partial volume averaging with CSF is evident by the upward deviation of the
b~0 data point relative to the dashed black line, due to the adjacent temporal horn
of the lateral ventricle. Like the gray matter ROI in Figure 1, the three data points
with b ≥ 680 s/mm2 fall on the straight solid red line, suggesting monoexponential
decay over the b value range of 680-1412 s/mm2.
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studies of the fornix have employed such a method,
however, which is likely due to limited recognition
of CSF PVEs and the limitations of prior corrective
techniques in DTI. The outcomes reported by Baron
and Beaulieu (8) indicate that CSF suppression using
a non-zero b-minimum and shorter TR causes fewer
voxels to be missed during tractography, translating
to greater accuracy of diffusion measurements. Our
study (75) also reveals that removal of b~0 data from
the analysis results in more sensitive detection of
age effects in gray matter of the right temporal lobe
(Figure 2), and removes CSF effects from white matter
regions adjacent to CSF spaces (Figure 3).
To date, there has been limited research on water diffusion in gray matter using CSF suppression
techniques. Interpretation of diffusion measurements
in gray matter is less straightforward compared to
interpretations of white matter measurements due
to greater isotropic diffusion and cellular heterogeneity inherent in gray matter. Deep gray matter
areas are also occupied by fluid-filled Virchow-Robin
spaces (VRSs) that contribute relatively high signal
intensity on b~0 images and may alter overall voxel
diffusion measurements. The results of our study
offer resolution to CSF contamination of gray matter
through the removal of b~0 data and tensor fitting
of data ranging in b values from 680 to 1412 s/mm2
(75). We also postulate that our technique may be
effective at suppressing water-like signal in VRSs in
addition to CSF. Enlarged VRSs (>2mm) are commonly observed in the basal ganglia of older adults
(97). In our opinion, it is still preferred to acquire
b~0 data (at little cost in scan time) because it can
be included in the analysis of regions not affected by
CSF-like PVEs, thus increasing SNR. Collectively, the
two methods described by Salminen et al. (75) and
Baron and Beaulieu (8) can be considered no-b-zero
(NBZ) approaches to CSF suppression. Unlike the
previously discussed methods, NBZ methods do not
depend on a model of CSF or tissue signal (i.e., are
model-independent), and CSF is suppressed regardless of CSF flow pattern or T1 value.
The observation that CSF contamination was evident in both NBZ studies suggests that outcomes of
earlier investigations utilizing DTI have likely been
impacted to some degree by CSF PVEs in certain

brain regions. This is particularly true in studies of
older individuals in whom age-related physiologic
factors (e.g., ventricular enlargement, sulcal expansion) increase the propensity for CSF PVEs. The CSF
suppression techniques proposed by our group (75)
and Baron and Beauleiu (8) offer promising alternatives to former correction methods by robustly reducing the CSF signal to negligible levels in both gray
and white matter, thereby improving the biological
approximation of the DTI measurements. As such,
there are several implications for using this technique
in conjunction with numerous imaging modalities
and data processing schemes. For the remainder of
this review, we will discuss potential uses of CSFsuppressed DTI in general, and the NBZ approaches
in particular.
NEW APPLICATIONS OF CSF-SUPPRESSED DTI
AND FUTURE INNOVATION
To date, CSF-suppressed DTI using a model-free
NBZ approach has been utilized in only two studies
(8,75), both of which focused on older adults without
neurologic disease. The potential for CSF suppression
to improve the accuracy of DTI metrics in neurological populations represents an important direction
for future research. Small vessel ischemic disease is
common among older individuals and is related to
poorer cognitive performance in otherwise healthy
adults, which may progress to vascular dementia in
some individuals (61). Further, vascular disease has
been hypothesized to represent a risk factor for the
subsequent development of Alzheimer’s disease (AD)
(36,50). CSF-suppressed DTI, particularly using a
NBZ approach, may help identify key mechanisms of
neurological dysfunction in these clinical conditions.
Similarly, while standard DTI has been utilized to
examine multiple sclerosis and HIV-associated brain
dysfunction, the neuroimaging signatures associated
with these conditions are significantly complicated
by acute inflammatory fluctuations (16,71,74), resulting in variable outcomes across studies. Application
of CSF-suppressed DTI has the potential to more
accurately characterize tissue microstructure in these
conditions to improve clinical assessment and patient
care strategies.
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Multimodal MR Imaging
An additional opportunity for future applications
of CSF-suppressed DTI includes multimodal imaging. The neuroimaging field is evolving towards the
integration of multiple forms of imaging outcomes
from various modalities. Multimodal imaging capitalizes on the strengths of different modalities that
are uniquely valuable at detecting abnormalities in
brain tissue across multiple neural systems. While
many studies have applied different MR imaging
sequences in parallel within a population (e.g., anatomical MRI, DTI, magnetic resonance spectroscopy
(MRS), and resting state functional MRI (rs-fMRI))
(25,30,32,79,81,94), integration of outcomes from
different MRI modalities into a unified and meaningful explanatory model of brain structure/function
represents a future innovation in brain imaging.
Ajilore et al. (1) revealed the relative power of
multimodal MR imaging compared to single modality
imaging by integrating rs-fMRI with DTI to create a
functional-by-structural hierarchical (FSH) map. This
study revealed clinically relevant brain abnormalities
that were not evident when either DTI or rs-fMRI
outcomes were analyzed separately. These results
demonstrate enhanced sensitivity of multimodal
imaging to detect alterations in the brain connectome over single modality imaging. Implementing
CSF-suppressed DTI has the potential to enhance
FSH mapping by removing CSF contamination from
voxels along white matter track lines that are adjacent
to CSF spaces, resulting in a more accurate depiction
of tract anatomy and more accurate measurement of
tract metrics, such as tract anisotropy and mean fiber
bundle length.
Machine Learning
Another area of innovation involves machine
learning approaches. Machine learning is an area of
artificial intelligence that can detect spatially distributed patterns within a group (48). Earlier imaging
studies utilized machine learning techniques such
as support vector machine (SVM) analysis to classify patterns of brain activation across individuals
(62,67,85). New applications of machine learning
include pattern recognition through high-level,
multidimensional clustering. The advantage of this
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technique is that it automatically detects regularities
in imaging data across disparate datasets (77). These
regularities can be used to generate predictions for
ascribing cognitive states to patterns of brain activity. As such, machine learning allows for automated
pattern recognition that can be used as a diagnostic
tool for complex diseases (62). SVM has been used
to facilitate differential diagnoses of complex diseases
(38,40), distinguish mild forms of AD from aging,
distinguish individuals with clinically asymptomatic conditions from normal controls (39,73), define
behavioral subtypes of clinical conditions (24), and
reliably fit functional activity signals to genetic networks (20,89,93).
Machine learning is not without limitations.
Specifically, while machine learning is designed to
manage complex and heterogeneous data, the method
becomes less reliable when there are image artifacts or
variations in imaging acquisition procedures (23,83).
Machine learning also requires large data sets, often
acquired at multiple project centers. CSF-suppressed
DTI may be one solution for reducing the variance
of multicenter DTI data, as some of the variance
could be a result of CSF PVEs and inconsistent CSFcorrection strategies. Studies are needed to confirm
whether CSF-suppressed DTI effectively stabilizes the
variance of DTI metrics and improves the accuracy
of future prediction models.
CONCLUSIONS
In the midst of remarkable technological advancement and innovation, our ability to improve health
and the human condition has increased dramatically,
but the human brain remains the greatest mystery in
medical science. While advances in medical oncology, pathobiology, immunology, and microbiology
provide demonstrable benchmarks toward the understanding and treatment of diseases such as cancer, diabetes, HIV, ebola, etc., the understanding and
treatment of many brain disorders remain elusive.
Noninvasive neuroimaging is one of the most powerful tools in our arsenal to reveal biological signatures
of human brain pathology. CSF-suppressed DTI, and
in particular the NBZ approaches, offer a new frontier
of imaging research that may yield measurements of
increased biological value. By reducing signal artifact
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and measurement bias, we can remove more barriers of uncertainty, which will allow us to unveil the
dynamic physiological and microstructural mechanisms of the normal and disordered brain. Pushing
the conventions of neuroimaging technology will
continue to boost the value of data it yields and help
solve the mysteries of this remarkably complex organ.
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